We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Caesars Entertainment
CZR
$6.05B
| $5.36M | 0.01% |
134,814
+29,705
| +28% | +$1.12M |
|
|
NEE.PRR
702
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| $5.35M | 0.01% |
129,000
| – | – |
|
703
Workiva
WK
$3.96B
| $5.33M | 0.01% |
73,053
-4,876
| -6% | -$384K |
|
704
Tenaris
TS
$28.4B
| $5.29M | 0.01% |
173,408
-39,038
| -18% | -$1.35M |
|
705
FNB Corp
FNB
$6.37B
| $5.26M | 0.01% |
384,142
+140
| +0% | +$1.89K |
|
706
KB Home
KBH
$2.98B
| $5.21M | 0.01% |
74,219
-74,873
| -50% | -$5.1M |
|
707
Tactile Systems Technology
TCMD
$502M
| $5.18M | 0.01% |
433,660
+90,960
| +27% | +$1.22M |
|
708
CME Group
CME
$98B
| $5.17M | 0.01% |
26,286
+532
| +2% | +$110K |
|
709
Chord Energy
CHRD
$8.04B
| $5.16M | 0.01% |
30,755
-9,924
| -24% | -$1.76M |
|
710
Exelixis
EXEL
$14.1B
| $5.12M | 0.01% |
227,909
+2,333
| +1% | +$51.8K |
|
711
Savers
SVV
$1.4B
| $5.1M | 0.01% |
417,000
-43,000
| -9% | -$642K |
|
712
Diageo
DEO
$48.3B
| $5.07M | 0.01% |
+40,218
| New | +$5.54M |
|
713
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $5.04M | 0.01% |
+111,000
| New | +$4.99M |
|
|
XHR
714
Xenia Hotels & Resorts
XHR
$1.62B
| $5.03M | 0.01% |
350,833
+350,638
| +179,814% | +$5.07M |
|
715
Essential Properties Realty Trust
EPRT
$5.79B
| $4.98M | 0.01% |
179,539
+83,925
| +88% | +$2.24M |
|
716
Turning Point Brands
TPB
$1.41B
| $4.96M | 0.01% |
154,708
+109,983
| +246% | +$3.4M |
|
717
Vishay Intertechnology
VSH
$4.8B
| $4.96M | 0.01% |
222,545
-859
| -0.4% | -$19.4K |
|
718
Takeda Pharmaceutical
TAK
$59.5B
| $4.93M | 0.01% |
380,873
-209,700
| -36% | -$2.78M |
|
719
PennyMac Financial
PFSI
$3.43B
| $4.91M | 0.01% |
51,908
+396
| +0.8% | +$35.8K |
|
720
T-Mobile US
TMUS
$189B
| $4.87M | 0.01% |
27,639
-79,865
| -74% | -$13.4M |
|
721
BrightView Holdings
BV
$1.01B
| $4.83M | 0.01% |
363,530
+38
| +0% | +$484 |
|
722
JB Hunt Transport Services
JBHT
$22.2B
| $4.71M | 0.01% |
29,456
-124
| -0.4% | -$20.8K |
|
723
Arvinas
ARVN
$534M
| $4.69M | 0.01% |
176,352
+4,389
| +3% | +$140K |
|
724
Medifast
MED
$134M
| $4.69M | 0.01% |
215,090
+173,337
| +415% | +$4.62M |
|
725
Adtran
ADTN
$578M
| $4.69M | 0.01% |
891,710
-918,979
| -51% | -$4.68M |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.